FUS protein in stress granules

Short updates on ALS research: KNS-760704, FUS protein in stress granules, SOD1 and mitochondria

Posted on Friday, August 27, 2010 - 11:23, By: Margaret Wahl
Biogen Idec and Knopp Neurosciences announced Aug. 18, 2010, that they have entered into an agreement to continue developing KNS-760704 (dexpramipexole) as an experimental treatment for ALS. The drug helps protect nerve cells under adverse conditions. A phase 2 trial by Knopp showed the drug had...